Related references
Note: Only part of the references are listed.Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors
Baocun Sun et al.
ONCOTARGET (2017)
Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma
Saba Mohamed El-Gendi et al.
PATHOLOGY & ONCOLOGY RESEARCH (2016)
CBX4 Suppresses Metastasis via Recruitment of HDAC3 to the Runx2 Promoter in Colorectal Carcinoma
Xin Wang et al.
CANCER RESEARCH (2016)
Role of epithelial to mesenchymal transition in hepatocellular carcinoma
Gianluigi Giannelli et al.
JOURNAL OF HEPATOLOGY (2016)
A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or sorafenib
Manuel A. de la Torre et al.
LIVER INTERNATIONAL (2016)
Vasculogenic mimicry in hepatocellular carcinoma contributes to portal vein invasion
Chen Jue et al.
ONCOTARGET (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway
Xiao-Qing Li et al.
CANCER RESEARCH (2015)
Advanced research on vasculogenic mimicry in cancer
Lili Qiao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Hepatocellular carcinoma epidemiology
Cristina Bosetti et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2014)
RUNX2 is overexpressed in melanoma cells and mediates their migration and invasion
Rajeev K. Boregowda et al.
CANCER LETTERS (2014)
Galectin-3 in angiogenesis and metastasis
Tatsuyoshi Funasaka et al.
GLYCOBIOLOGY (2014)
Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
Shan-Shan Jiang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Doxycycline as an Inhibitor of the Epithelial-to-Mesenchymal Transition and Vasculogenic Mimicry in Hepatocellular Carcinoma
Jie Meng et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Galectin-3 Accelerates the Progression of Oral Tongue Squamous Cell Carcinoma via a Wnt/beta-catenin-Dependent Pathway
Li-Ping Wang et al.
PATHOLOGY & ONCOLOGY RESEARCH (2013)
A new perspective of vasculogenic mimicry: EMT and cancer stem cells
Yun-Long Fan et al.
ONCOLOGY LETTERS (2013)
Runt-related transcription factor 2 in human colon carcinoma: A potent prognostic factor associated with estrogen receptor
Tomohiko Sase et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Transcription factor Runx2 is a regulator of epithelial-mesenchymal transition and invasion in thyroid carcinomas
Dong-Feng Niu et al.
LABORATORY INVESTIGATION (2012)
Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2
Nyam-Osor Chimge et al.
BREAST CANCER RESEARCH (2011)
Runx2 in normal tissues and cancer cells: A developing story
Karen Blyth et al.
BLOOD CELLS MOLECULES AND DISEASES (2010)
Expression and Functional Significance of Twist1 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry
Tao Sun et al.
HEPATOLOGY (2010)
Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis
Sanjeev K. Baniwal et al.
MOLECULAR CANCER (2010)
Biomarkers for epithelial-mesenchymal transitions
Michael Zeisberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Prognosis of hepatocellular carcinoma accompanied by microscopic portal vein invasion
Ken Shirabe et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Expression Profiling of Galectin-3-Depleted Melanoma Cells Reveals Its Major Role in Melanoma Cell Plasticity and Vasculogenic Mimicry
Alexandra A. Mourad-Zeidan et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
VE-cadherin - The major endothelial adhesion molecule controlling cellular junctions and blood vessel formation
Dietmar Vestweber
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Runx2 is expressed in human glioma cells and mediates the expression of galectin-3
Valentina Vladimirova et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Vasculogenic mimicry: Current status and future prospects
Shiwu Zhang et al.
CANCER LETTERS (2007)
Morphologic research of microcirculation patterns in human and animal melanoma
Shiwu Zhang et al.
MEDICAL ONCOLOGY (2006)
The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion
J Pratap et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Molecular requirements for epithelial-mesenchymal transition during tumor progression
MA Huber et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Expression of galectin-3 in skeletal tissues is controlled by Runx2
M Stock et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Runx2, a multifunctional transcription factor in skeletal development
T Komori
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
Share Paper
